Long-COVID symptoms improved with neuromodulation
All twenty long-COVID patients who received neuromodulation treatment reported significant improvements in their symptoms in just 14 days.
List view / Grid view
All twenty long-COVID patients who received neuromodulation treatment reported significant improvements in their symptoms in just 14 days.
ISO 10993-18:2020 outlines the chemical characterisation tests that manufacturers must undertake to support the biological safety of their medical devices.
A new perspective of digital transformation in a terminal sterilisation process of medical devices such as syringes used for Covid-19 vaccination.
In this article, EPR’s Hannah Balfour discusses the potential impact of waiving intellectual property rights for COVID-19-related medicine and technology on pharma, biopharma and biotech companies.
neuroloop and Merck will combine their expertise to develop a neurostimulator that can safely and effectively treat chronic inflammatory diseases.
Here, industry experts share their research, guidance and pharmaceutical knowledge.
Fever is something that most of us have experienced. However, when we use medicines or medical devices, we expect them to improve our health – not to cause a fever.
A strategic European health research and innovation agenda is being compiled by five industry associations and the European Commission.
An in silico trial evaluating a flow diverter in the treatment of brain aneurysms simulated the results of three human clinical trials.
Endotoxin automation using microfluidics enables simpler, compliant processes for pharma QC, QA, validation and IT. BET assay setup is simplified and less LAL is required.
Endotoxin automation doesn’t mean complex instrumentation and setup. See how microfluidics enables easy BET assay setup so QC labs achieve high throughput with less hands-on time.
Professor Tom Clutton-Brock was awarded an MBE for his work in approving novel ventilators for the UK’s National Health Service during the COVID-19 pandemic.
A rapid sterility test method that can be validated as quickly and confidently as it provides test results.
In this article, Giacomo Chiesi from Chiesi Group outlines why the company took steps to become Benefit Corporation and B Corp certified, how this status may impact business and the associated operations.
This webinar presents the fundamentals of a contamination control strategy including forms of contamination, as well as cleaning and disinfection.